Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
TREK-1 is a two-pore-domain potassium (K2P) channel that plays a crucial role in maintaining the resting membrane potential and regulating cell excitability, especially within the central nervous system and heart. It is activated by a variety of stimuli including polyunsaturated fatty acids, mechanical stretch, intracellular acidosis, and heat, and inhibited by neurotransmitters that increase intracellular cAMP or activate Gq protein pathways. Altered TREK-1 function has been linked to epilepsy, ischemic injury, and migraine, making it a potential therapeutic target for neurological disorders, pain management, and cardiovascular diseases.
Modulation of neuronal excitability and cardiac function
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Two-Pore Domain Potassium Channel TREK-1 (TREK-1).